Community outbreaks of group A Streptococcus revealed by genome sequencing

[1]  R. Lynfield,et al.  Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  K. Jolley,et al.  Integration of Genomic and Other Epidemiologic Data to Investigate and Control a Cross-Institutional Outbreak of Streptococcus pyogenes , 2016, Emerging infectious diseases.

[3]  A. Efstratiou,et al.  Emergence of a novel lineage containing a prophage in emm/M3 group A Streptococcus associated with upsurge in invasive disease in the UK , 2016, Microbial genomics.

[4]  A. Efstratiou,et al.  Scarlet Fever Upsurge in England and Molecular-Genetic Analysis in North-West London, 2014 , 2016, Emerging infectious diseases.

[5]  J. McVernon,et al.  Whole genome sequencing reveals extensive community-level transmission of group A Streptococcus in remote communities , 2016, Epidemiology and Infection.

[6]  F. Ruffin,et al.  Application of Whole-Genome Sequencing to an Unusual Outbreak of Invasive Group A Streptococcal Disease , 2016, Open forum infectious diseases.

[7]  João Carriço,et al.  Emergence of the Same Successful Clade among Distinct Populations of emm89 Streptococcus pyogenes in Multiple Geographic Regions , 2015, mBio.

[8]  K. Dewar,et al.  High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of Uncommon emm Types in Thunder Bay, Ontario, Canada , 2015, Journal of Clinical Microbiology.

[9]  R. Olsen,et al.  Trading Capsule for Increased Cytotoxin Production: Contribution to Virulence of a Newly Emerged Clade of emm89 Streptococcus pyogenes , 2015, mBio.

[10]  R. Olsen,et al.  A molecular trigger for intercontinental epidemics of group A Streptococcus. , 2015, The Journal of clinical investigation.

[11]  Michael D. Jones,et al.  Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom , 2015, mBio.

[12]  Andrew J. Page,et al.  Roary: rapid large-scale prokaryote pan genome analysis , 2015, bioRxiv.

[13]  G. Dougan,et al.  Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance , 2014, Nature Genetics.

[14]  J. Carapetis,et al.  Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  L. Chang,et al.  Association between polymorphisms in the csrRS two-component regulatory system and invasive group A streptococcal infection , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[16]  S. W. Long,et al.  Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences , 2014, Proceedings of the National Academy of Sciences.

[17]  G. Dougan,et al.  RocA Truncation Underpins Hyper-Encapsulation, Carriage Longevity and Transmissibility of Serotype M18 Group A Streptococci , 2013, PLoS pathogens.

[18]  S. Bentley,et al.  Molecular Analysis of an Outbreak of Lethal Postpartum Sepsis Caused by Streptococcus pyogenes , 2013, Journal of Clinical Microbiology.

[19]  D. Lin,et al.  Integrated whole-genome sequencing and temporospatial analysis of a continuing Group A Streptococcus epidemic , 2013, Emerging Microbes & Infections.

[20]  B. Spratt,et al.  Superantigenic Activity of emm3 Streptococcus pyogenes Is Abrogated by a Conserved, Naturally Occurring smeZ Mutation , 2012, PloS one.

[21]  R. Olsen,et al.  Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus. , 2012, The American journal of pathology.

[22]  Antonis Rokas,et al.  Phylogenetic Analysis of Protein Sequence Data Using the Randomized Axelerated Maximum Likelihood (RAXML) Program , 2011, Current protocols in molecular biology.

[23]  Yuriy Fofanov,et al.  Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics , 2010, Proceedings of the National Academy of Sciences.

[24]  J. Carapetis,et al.  Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. , 2009, The Lancet. Infectious diseases.

[25]  Michael D. Jones,et al.  Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. , 2009, The Journal of infectious diseases.

[26]  B. Henriques-Normark,et al.  Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe , 2009, Journal of Clinical Microbiology.

[27]  B. Henriques-Normark,et al.  Epidemiology of Severe Streptococcus pyogenes Disease in Europe , 2008, Journal of Clinical Microbiology.

[28]  E. Birney,et al.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs. , 2008, Genome research.

[29]  Z. Mulla,et al.  Epidemiology of invasive group a streptococcal infection in the United States. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  Edward A Graviss,et al.  Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease Specificity , 2006, PLoS pathogens.

[31]  J. Carapetis,et al.  The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.

[32]  J. Musser,et al.  Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. , 2005, The Journal of infectious diseases.

[33]  N. Barg.  Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus. , 1998, The Journal of antimicrobial chemotherapy.

[34]  M. Skurnik,et al.  A Novel Erythromycin Resistance Methylase Gene (ermTR) in Streptococcus pyogenes , 1998, Antimicrobial Agents and Chemotherapy.

[35]  Stevens Dl,et al.  Streptococcus pyogenes: Basic Biology to Clinical Manifestations , 2016 .

[36]  J. Stuart,et al.  Global assessment of invasive group a streptococcus infection risk in household contacts. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  M. Morgan,et al.  Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK. , 2012, The Journal of infection.